UA40408A - METHOD OF COMBINED TREATMENT OF THYROID CANCER - Google Patents

METHOD OF COMBINED TREATMENT OF THYROID CANCER

Info

Publication number
UA40408A
UA40408A UA2001010183A UA200110183A UA40408A UA 40408 A UA40408 A UA 40408A UA 2001010183 A UA2001010183 A UA 2001010183A UA 200110183 A UA200110183 A UA 200110183A UA 40408 A UA40408 A UA 40408A
Authority
UA
Ukraine
Prior art keywords
thyroid cancer
combined treatment
cryotherapy
exposure
cryonecrosis
Prior art date
Application number
UA2001010183A
Other languages
Ukrainian (uk)
Inventor
Микола Іванович Пилипенко
Николай Иванович Плипенко
Василь Григорович Щевцов
Наталія Іванівна Афанасьєва
Наталья Ивановна Афанасьева
Original Assignee
Інститут Медичної Радіології Ім. С.П. Григор'Єва Амн України
Институт Медицинской Радиологии Им. С.П. Григорьева Амн Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Медичної Радіології Ім. С.П. Григор'Єва Амн України, Институт Медицинской Радиологии Им. С.П. Григорьева Амн Украины filed Critical Інститут Медичної Радіології Ім. С.П. Григор'Єва Амн України
Priority to UA2001010183A priority Critical patent/UA40408A/en
Publication of UA40408A publication Critical patent/UA40408A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Реферат Спосіб комбінованого лікування раку щитовидної залози полягає у хірургічному втручанні та інтраопераційному кріодеструкціюванні пухлини. Кріодіяння здійснюється під контролем УЗД неодноразово, при цьому експозицію кожного кріодіяння розраховують за формулою: t = 2,049L1,550[ 2+Tn / 100], де t- експозиція кріодіяння; L- глибина кріонекрозу; Т- температура джерела.Summary The method of combined treatment of thyroid cancer is surgery and intraoperative cryodestruction of the tumor. Cryotherapy is carried out under the control of ultrasound repeatedly, with the exposure of each cryotherapy is calculated by the formula: t = 2,049L1,550 [2 + Tn / 100], where t is the exposure of cryotherapy; L- depth of cryonecrosis; T- source temperature.

UA2001010183A 2001-01-10 2001-01-10 METHOD OF COMBINED TREATMENT OF THYROID CANCER UA40408A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2001010183A UA40408A (en) 2001-01-10 2001-01-10 METHOD OF COMBINED TREATMENT OF THYROID CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2001010183A UA40408A (en) 2001-01-10 2001-01-10 METHOD OF COMBINED TREATMENT OF THYROID CANCER

Publications (1)

Publication Number Publication Date
UA40408A true UA40408A (en) 2001-07-16

Family

ID=74290715

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001010183A UA40408A (en) 2001-01-10 2001-01-10 METHOD OF COMBINED TREATMENT OF THYROID CANCER

Country Status (1)

Country Link
UA (1) UA40408A (en)

Similar Documents

Publication Publication Date Title
ATE468137T1 (en) INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES
MXPA03006771A (en) Modified antibodies and methods of use.
NO20044475L (en) 2- (2,6-dichlorophenyl) -diarulimidazoler
ATE240744T1 (en) USE OF CSF-1 INHIBITORS
DE60112974D1 (en) Carbolinderivate
BR0212924A (en) Glycogen synthase kinase-3 (gsk-3) inhibitors for the treatment of glaucoma
PL374865A1 (en) Treatment of tnf alpha related disorders
EA200300717A1 (en) Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands
EA200300544A1 (en) EFFECTIVE ANTI-TUMOR MEDICINE
NO20022065L (en) Therapeutic use
NO20071585L (en) New use of peptide compounds for the treatment of bone pain, chemotherapy and nucleoside induced pain
DE60216233D1 (en) Carbolinderivate
CY1115407T1 (en) THORIO-227 FOR USE IN SOFT TISSUE RADIATION
BR0316458A (en) Compound, pharmaceutical composition, method of treating or preventing disease, method for enhancing cognition in a healthy patient, and use of a compound
SE0102147D0 (en) New methods
TR200101693T2 (en) Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway.
DE60224299D1 (en) COMBINATION MEDICATIONS WITH A SELECTIVE CYCLOOXYGENASE 2 INHIBITOR
UA40408A (en) METHOD OF COMBINED TREATMENT OF THYROID CANCER
DE50211672D1 (en) Urokinase INHIBITORS
DE60121048D1 (en) PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60206599D1 (en) BIOTIN DERIVATIVES AND THEIR CONJUGATES WITH CHELATING AGENTS
MXPA01007952A (en) L-arginine based formulations for treating diseases and methods of using same.
BR9007080A (en) APPLICATION OF 1,2-BENZOPYRONE DERIVATIVES FOR THE TREATMENT OF MALIGNANT TUMORS IN MEN
BG102177A (en) Surgical method for organconservation treatment of cancer of the mammary gland
RU2001129092A (en) The method of Chernozubov I.E. disease treatment